Target intelligence / Profile preview

Snurportin-1 (SNUPN)

Target
SNUPN
Molecular classification
Nuclear import adaptor, m3G cap-binding protein, Transporter (for snRNPs), Other (due to unique mechanism and specialization)
01

Overview

Snurportin-1 (SNUPN) is a 360-amino acid nuclear import adaptor protein encoded by the SNUPN gene on human chromosome 15. It binds the trimethylguanosine (m3G) cap found on spliceosomal U snRNPs and interacts with Importin-β1 to mediate snRNP transport into the nucleus, a process essential for proper spliceosome assembly and mRNA processing. The protein has an Importin-β binding domain (IBB) at the N-terminus and a m3G-cap binding region at the C-terminus. Deficiency or mutation in SNUPN leads to defective spliceosomal maturation, cytoskeletal disorganization, and Mendelian recessive muscular dystrophy (LGMDR29), with associated neurological phenotypes. Snurportin-1 is not a drug target or receptor but is essential for normal nuclear transport and gene expression regulation in muscle and neuronal tissues. No interacting drugs or safety concerns are described, and while disease-causing mutations exist, its role as a marker is limited to rare inherited disease diagnosis.

Other names
SNUPNSPN1RNUT1SNURPORTIN-1Snurportin1RNA U transporter 1KPNBLLGMDR29
02

Biological functions

Nuclear import of spliceosomal U snRNPs (U1, U2, U4, U5)mRNA splicingMaintenance of cytoskeletal and ECM-cytoskeleton organizationMuscle homeostasis and spliceosomal maturation
03

Disease associations

Muscular dystrophy, limb-girdle, autosomal recessive 29 (LGMDR29)Muscular dystrophy (general)Neurodegeneration (associated with loss of function)Cataracts (reported in some patients with SNUPN deficiency)

Beyond the preview

Go deeper on Snurportin-1 (SNUPN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Snurportin-1 (SNUPN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call